
Lakia J. Jackson-tongue
Examiner (ID: 14732, Phone: (571)272-2921 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 886 |
| Issued Applications | 525 |
| Pending Applications | 104 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18784777
[patent_doc_number] => 20230372409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => SOLID DOSAGE FORMS OF BACTERIA
[patent_app_type] => utility
[patent_app_number] => 18/027003
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -116
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027003
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027003 | SOLID DOSAGE FORMS OF BACTERIA | Sep 16, 2021 | Pending |
Array
(
[id] => 18799973
[patent_doc_number] => 11833116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Preparation method of yeast powder rich in nicotinamide mononucleotide, yeast powder, and methods for improving skin condition, hair health, antiinflammation, cardiovascular health, antioxidation, antiaging and/or relieving body fatigue
[patent_app_type] => utility
[patent_app_number] => 17/411067
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 17004
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/411067 | Preparation method of yeast powder rich in nicotinamide mononucleotide, yeast powder, and methods for improving skin condition, hair health, antiinflammation, cardiovascular health, antioxidation, antiaging and/or relieving body fatigue | Aug 24, 2021 | Issued |
Array
(
[id] => 18923276
[patent_doc_number] => 20240026280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => PLASMID ADDICTION SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/022895
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -112
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022895
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022895 | PLASMID ADDICTION SYSTEMS | Aug 22, 2021 | Pending |
Array
(
[id] => 17838893
[patent_doc_number] => 20220276198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => CHEMICAL SENSOR DEVICE AND CHEMICAL SENSOR MODULE
[patent_app_type] => utility
[patent_app_number] => 17/402220
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17402220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/402220 | Chemical sensor device and chemical sensor module | Aug 12, 2021 | Issued |
Array
(
[id] => 17428405
[patent_doc_number] => 20220056113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => ANTI-O1 ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/397474
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397474 | Anti-O1 antibodies and uses thereof | Aug 8, 2021 | Issued |
Array
(
[id] => 17593598
[patent_doc_number] => 20220143171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => CD40 LIGAND FUSION PROTEIN VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/391103
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391103 | CD40 LIGAND FUSION PROTEIN VACCINE | Aug 1, 2021 | Abandoned |
Array
(
[id] => 19563552
[patent_doc_number] => 12138303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/389982
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 32
[patent_no_of_words] => 23121
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389982
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389982 | None | Jul 29, 2021 | Issued |
Array
(
[id] => 18938087
[patent_doc_number] => 20240033226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => CHITOSAN-Fe COATING-BASED SYNBIOTIC MICROCAPSULE WITH GASTRIC ACID RESISTANCE AND INTESTINAL TARGETED RELEASE AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/015193
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015193
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015193 | CHITOSAN-Fe COATING-BASED SYNBIOTIC MICROCAPSULE WITH GASTRIC ACID RESISTANCE AND INTESTINAL TARGETED RELEASE AND PREPARATION METHOD THEREOF | Jul 22, 2021 | Pending |
Array
(
[id] => 18583183
[patent_doc_number] => 20230265443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => REDUCTION OF FATTY ACID RETINYL ESTER FORMATION
[patent_app_type] => utility
[patent_app_number] => 18/017819
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017819
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017819 | REDUCTION OF FATTY ACID RETINYL ESTER FORMATION | Jul 21, 2021 | Pending |
Array
(
[id] => 17355388
[patent_doc_number] => 20220016184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/382426
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/382426 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Jul 21, 2021 | Abandoned |
Array
(
[id] => 18626780
[patent_doc_number] => 20230285588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => SUPERANTIGEN CONJUGATE FOR USE IN METHODS AND COMPOSITIONS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/006243
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006243
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006243 | SUPERANTIGEN CONJUGATE FOR USE IN METHODS AND COMPOSITIONS FOR TREATING CANCER | Jul 19, 2021 | Pending |
Array
(
[id] => 19474084
[patent_doc_number] => 12104161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Production of soluble recombinant proteins without N-terminal methionine in
[patent_app_type] => utility
[patent_app_number] => 17/371449
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10051
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371449 | Production of soluble recombinant proteins without N-terminal methionine in | Jul 8, 2021 | Issued |
Array
(
[id] => 17183835
[patent_doc_number] => 20210330720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOSITION AND METHODS FOR MICROBIOTA THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/368494
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368494 | Composition and methods for microbiota therapy | Jul 5, 2021 | Issued |
Array
(
[id] => 17183890
[patent_doc_number] => 20210330775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT
[patent_app_type] => utility
[patent_app_number] => 17/305236
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305236 | Vaccine for protection against ETEC-induced diarrhea comprising dmLT | Jun 30, 2021 | Issued |
Array
(
[id] => 20592402
[patent_doc_number] => 12576098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Saponin containing extracts prepared from
[patent_app_type] => utility
[patent_app_number] => 18/011326
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 4209
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011326
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011326 | Saponin containing extracts prepared from | Jun 20, 2021 | Issued |
Array
(
[id] => 17274454
[patent_doc_number] => 20210380652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/346452
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346452 | Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use | Jun 13, 2021 | Issued |
Array
(
[id] => 17290961
[patent_doc_number] => 20210386800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROLOGICAL OR MENTAL DISORDERS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM LACTOBACILLUS PARACASEI
[patent_app_type] => utility
[patent_app_number] => 17/343901
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343901 | Composition for prevention or treatment of neurological or mental disorders comprising extracellular vesicles derived from | Jun 9, 2021 | Issued |
Array
(
[id] => 20232763
[patent_doc_number] => 20250290082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => FERMENTATION METHOD FOR PRODUCING MALONIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/564939
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564939
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564939 | FERMENTATION METHOD FOR PRODUCING MALONIC ACID | May 27, 2021 | Pending |
Array
(
[id] => 17095456
[patent_doc_number] => 20210283247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/328657
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328657 | PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES | May 23, 2021 | Abandoned |
Array
(
[id] => 18522969
[patent_doc_number] => 20230233620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => HIGH-COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES
[patent_app_type] => utility
[patent_app_number] => 17/999516
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999516 | HIGH-COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES | May 20, 2021 | Pending |